Abstract. Microtubule-associated protein tau (MAPT) is the major component of the neurofibrillary tangles found in the brains of those suffering from Alzheimer's disease. Various forms of tau lesions are found in other neurodegenerative diseases (tauopathies). We report identification of two MAPT paralogous genes in zebrafish, mapta and maptb, and analysis of their expression patterns during embryonic development. The two paralogues appear to have arisen by duplication of an ancestral teleost MAPT orthologue. Analysis of the splicing of transcripts from both genes during embryogenesis showed that mapta can be spliced into isoforms with between four and six tubulin-binding repeats (4R-6R), while maptb is mainly spliced into 3R isoforms. Expression of both genes is observed predominantly in the developing central nervous system. A particularly large isoform of maptb is specifically expressed in the trigeminal ganglion and in dorsal sensory neurons of the spinal cord. Changes in the subcellular ratio of 3R and 4R isoforms can have pathological consequences in mammals. The predominant production of 4R-6R isoforms from mapta and of 3R isoforms from maptb suggests that zebrafish embryos will be a useful tool with which to study the discrete functions and interactions of the 3R and 4R MAPT isoforms.
INTRODUCTION
The dysfunction of microtubule-associated protein tau (MAPT) is a major histological characteristic of Alzheimer's disease (AD) and is a common factor in a number of other neurodegenerative disorders including frontotemporal dementia with Parkinson linked to chromosome 17 (FTDP-17), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP) [1] . In these diseases, collectively known as tauopathies, the normally soluble MAPT proteins aggregate to form lesions in neurons and, for CBD and PSP, in glial cells. The mechanism of the development of tau lesions is largely unknown and differs among diseases in terms of affected areas and accompanying histological symptoms [1] . However, the consistent presence of insoluble tau aggregations is undoubtedly an important component of these diseases.
Physiologically, the ubiquitously expressed MAPT protein functions as a stabilizer to associate microtubules in the human nervous system [2] . A large repertoire of protein isoforms resulting from alternative splicing of MAPT transcripts has been identified. However, only six isoforms are most commonly expressed in human brain [3] . These six isoforms can be classified into two groups, referred to as 3R or 4R, depending on the number of tubulin-binding motifs (the presence or absence of exon10 sequence) in their C-termini. Each group contains three isoforms derived from alternative splicing of exon 2 and 3 [3] .
The MAPT isoforms are differentially expressed during neuronal development. The shortest isoform is predominantly expressed in human fetus. However, equal levels of 3R and 4R transcripts are found in adult brains [4] . This precise one-to-one ratio appears to be important for maintaining the physiological function of the MAPT protein and is altered in most of the neurodegenerative disorders mentioned above in a diseasespecific manner [5] . In AD, most early studies failed to find any significant changes in isoform content [6] [7] [8] . However, a recent study has suggested that altered splicing occurs in AD-affected brains [9] . In addition to changes in isoform composition, MAPT dysregulation is also characterized by abnormal hyperphosphorylation of the MAPT protein, which detaches MAPT from microtubules and leads to the aggregation of the hyperphosphorylated MAPT protein into pretangles, paired helical filaments, neuropil threads, or neurofibrillary tangles [10] . Much remains unknown about the direct inducers and effectors of tau dysregulation. However, tau dysregulation is correlated with the extensive neuron loss and cognitive decline observed in the relevant neurodegenerative diseases. The intimate participation of MAPT in neurodegenerative disease has been substantiated further by the identification of mutations in MAPT as a genetic risk for FTDP-17 [11] . These observations make MAPT an interesting gene both in terms of furthering our understanding of the mechanisms underlying these neurodegenerative diseases and as a potential therapeutic target.
The zebrafish, Danio rerio, is an emerging model organism for the study of neurodegenerative disease. Zebrafish embryos can be subjected to subtle and complex manipulation of gene activity. Changes in gene activity can be monitored by observing corresponding changes in the development of their large and easily accessible embryos. Zebrafish embryos bearing mutations in genes orthologous to those involved in human diseases can provide models for dissection of gene function and can be used to screen for therapeutic drugs. In this paper, we report the identification of two MAPT paralogous genes in zebrafish, as well as their expression patterns during embryonic development.
MATERIALS AND METHODS

Phylogenetic and synteny analysis
The conserved regions of MAPT-related protein sequences were aligned using ClustalW (Table 1) with a gap opening penalty of 10 and gap extension penalty of 0.1 for the pairwise alignment stage and a gap opening penalty of 3.0 and gap extension penalty of 1.8 for the multiple alignment stage. The analyses were conducted using PHYML 3.0 [12] . The program was run under the GTR (General Time Reversible) model, with estimated proportion, estimated gamma distribution parameter, BIONJ input tree, and optimized tree topology. The tree reliability was estimated by the approximate Likelihood Ratio Test Method, using SH-like support.
For synteny analysis, the following loci were investigated: in human, region 41.2-59.4 M of chromosome 17; in mouse, region 103.6-106.2 M of chromosome 11; in chicken, region 1.1-2.9 M of chromosome 27; in zebrafish, region 18.9-32.5 M of chromosome 3 and region 2.6-20.0 M of chromosome 12. The genes contained in the above regions were compared using the Sanger Ensembl and NCBI Entrez Gene databases to identify homologues.
Cloning of maptb and mapta
Zebrafish cDNAs were generated from total RNA extracted from whole embryos at 24 hpf and 48 hpf, using Oligo-dT primers as previously described [13] . The maptb and mapta cDNA fragments were amplified by PCR from 24 hpf cDNA using primers: chr3t (5'-GGACAGACAATAACTCAGTGTGC-3' and CTTTT CTGGATTCGTCAGTAGCC-5') and chr12t (5'-CTAT GGACCAGCACCACGATTT-3' and 5'-TCACAAGC CCTGTTTGG-3') respectively. PCR was performed with Dynazyme (FINNZYMES Oy, Espoo, Finland) at an annealing temperature of 55
• C for 35 cycles. The extension time for PCR was 2 min. The PCR fragments were cloned into the pGEM-T vector (Promega) and sequenced.
To confirm the existence of 4R maptb isoforms, cD-NA fragments were amplified by PCR as above from 24 hpf cDNA using primers: S5 (5'-CATGTTCCTGGTG GTGGTAATG-3') and 3TRR (5'-GATCCAACCTTT GACTGGGCTT-3'); 3TRF (5'-AAGATCGGCTCCA CTGAGAACC-3') and R2 (5'-CACATTACCACCAC CAGGAACA-3'); 3TRF (5'-AAGATCGGCTCCACT GAGAACC-3') and 3TRR (5'-GATCCAACCTTTGA CTGGGCTT-3') (see Fig. 3 for primer locations). The PCR product amplified by 3TRF/R2 and S5/3TRR was then sequenced.
To study the coexistence in spliced transcripts of maptb exons 3, 5, 9 and 12, the following primers were used to amplify cDNA fragments from 48 hpf cD-NA: S1 (5'-TGGGAGCAGAAGCCTTAACACC-3'); 
To identify splicing transcript variants of mapta, primers that bind regions inside the open reading frame (ORF) were employed. cDNA fragments were amplified from 24 hpf cDNA using the following primers and then sequenced: chr12ts (5'-CTATGG ACCAGCACCACGATTT-3'); 12ts' (5'-TCCTAGTA-GCAGTAGACC-3'); 12tr' (5'-CCATGTTGAT GCT-GCCAGAG 3'); 12tas (5'-TCACAAGCCCTGTTT GG-3').
To check the existence of 3R mapta isoforms, RT-PCR was performed using primers: 12trf (5'-TCCAAAGTCGGGTCCACTGATA-3') and 12trr (5'-GTTGCCTCCTCCAGGTGTATGT-3'), using 24 hpf and 48 hpf cDNA as templates.
In situ hybridization
Whole-mount in situ transcript hybridization was conducted as previously described [14] , using singlestrand RNA probes labeled with digoxigenin-UTP. The probes were synthesized from maptb Variant 2, exon 3 and mapta Variant 1 templates. Double-staining using whole mount in situ transcript hybridization (WISH) combined with immunohistochemistry was performed essentially as described [15] , but the WISH staining reagent was BCIP/NBT. The first alkaline phosphatase staining reaction was inactivated by heating at 65
• C for 1h in PBT, and the antibody staining reaction used the Alkaline Phosphatase Substrate Kit I ("Vector Red", Vector Laboratories Inc. Burlingame, CA, USA). zn12 [16] antibody was used at a dilution of 1:200.
RESULTS
The identification of zebrafish tau genes via a phylogenetic approach
The MAPT gene belongs to the microtubule associated protein family. It has been unambiguously recognized in major mammals (e.g., human, mouse, and bovine), chickens, and frogs. To identify genes with possible orthology to MAPT in zebrafish, we searched the NCBI and Ensembl Genome databases using the human MAPT protein sequence.
We found two candidates, previously annotated as "similar to microtubule associated protein tau" in the NCBI database, located on chromosome 3 (XM 001919231) and chromosome 12 (XM 001340530). The E-Values of tBLASTn alignments between these two candidates and human MAPT are similar (1e-96 and 9e-84) and are significantly smaller than other alignments ( 1e-57),which suggests that the two candidates are homologues of human MAPT. The amino acid residue identities between human MAPT and the candidates in the conserved C-terminal regions are 62% and 58% respectively (Fig. 1A) . To examine the relationship between these candidates and human MAPT, we performed a phylogenetic analysis comparing the zebrafish genes with the DNA sequences of MAPT orthologues in human, mouse, frog, chicken, as well as the related proteins MAP2 in human, mouse, and frog, and MAP4 in human and mouse ( Table 1) . The results strongly support that an ancestral MAPT orthologue has been duplicated in zebrafish and that both the candidates are paralogues of human MAPT (Fig. 1B) .
Analysis of synteny conservation supports the results of the phylogenetic analysis
To support the proposed evolutionary relationship between the two candidates and MAPT, neighboring Table 1 .
genes on each side of the zebrafish candidate genes were investigated using the Sanger Ensembl database. This led to identification of zebrafish homologues of five genes that are syntenic with human MAPT either upstream (LOC587940, cdc27 and LOC567884) or downstream (scn4ab and nsf) of the chromosome 3 candidate and homologues of four genes syntenic with human MAPT either upstream (LOC564520) or downstream (scn4aa, LOC569420 and nsfb) of the chromosome 12 candidate. The human orthologi- cal relationships of the zebrafish genes cdc27 [17] , scn4aa/scn4ab [18] , and nsf [19] have been established previously. tBLASTn searches were performed to confirm that the other neighboring genes of human MAPT share highest sequential similarity with their presumptive orthologues in zebrafish ( Table 2 ). The locations of orthologues of these syntenic genes in mouse and chicken were also identified. Interestingly, the human gene KIAA1267 and its known or presumptive orthologues in other species exist in a head-to-head orientation with the MAPT orthologues in all the species investigated. In zebrafish, this gene is duplicated and appears upstream of both the chromosome 3 and chromosome 12 MAPT candidates (Fig. 2) . Thus, analysis of synteny supports that the two candidates are paralogues derived by duplication of an ancestral MAPT orthologue. Therefore we have renamed the chromosome 3 and chromosome 12 genes as maptb and mapta respectively (reflecting the order in which we analyzed them).
The structure of mapta and maptb transcripts
Reverse transcriptase PCR (RT-PCR) was employed to clone cDNAs derived from the mRNAs of zebrafish mapta and maptb. For mapta, we initially identified the existence of four isoforms derived from alternative splicing of exons 8,9, and 12, using primers 12ts', 12tr', and chr12tas (see Fig. 3A ). Inclusion of the 145 bp long exon 12, which follows the last of the exons encoding a tubulin-binding repeat, introduces a stop cordon and truncates the open reading frame (Fig. 3A) . Interestingly, exons 8 and 9 also encode tubulin-binding repeats. Thus zebrafish mapta can have four, five, or six tubulin-binding repeats due to alternative RNA splicing, while human MAPT only contains either three or four tubulin-binding repeats. To confirm whether mapta can produce an isoform with three tubulin-binding repeats, we performed a RT-PCR test, using primers flanking the entire set of tubulin-binding repeats. This failed to detect any 3R isoform of mapta in 24 hpf or 48 hpf embryos (data not shown). The entire ORF of mapta was then amplified and cloned using primer pair chr12ts and chr12tas (Fig. 3A) .
For maptb, three isoforms resulting from alternative RNA splicing were initially cloned and sequenced using primers targeting regions flanking the entire opening reading frame (ORF) (Fig. 3B,C) . Compared to the shortest isoform (splicing Variant 3), splicing Variant 1 of maptb includes a 139 bp insert (exon 12) after the tubulin-binding domain in its C-terminal region. Similar to mapta, inclusion of this exon truncates the ORF. Splicing Variant 2 of maptb includes a 58 amino acid residue insert (exon 5) in its N-terminal region (Fig. 3B) .
Interestingly, all of the three isoforms of maptb only contain three tubulin-binding repeat motifs in their C-terminal regions, while in adult human brain, approximately equal levels of 3R and 4R MAPT isoforms (that include three or four tubulin-binding repeats respectively) are present. We then asked whether the maptb gene can generate isoforms with four tubulinbinding motifs. To answer this, we used tBLASTn to search the Sanger Ensembl Genome database, using the sequence of the zebrafish tubulin-binding motif (GSKANIHHKPGGG). A potential exon was found in intron 8 (Fig. 3C) . We confirmed the existence of transcripts including this exon by RT-PCR (Fig. 3D) . However, the 3R isoforms of maptb in 24 hpf and 48 hpf embryos appear to dominate expression, since the 4R transcripts that include this cryptic exon (exon 9) can only be detected when one PCR primer is positioned within it and not when both primers flank the tubulin-binding repeat domain (data not shown).
The NCBI data based on a combination of ESTs and GNOMON gene-prediction suggested the exis- tence of a 1212 bp exon (exon 3) that can be alternatively spliced in maptb. We confirmed the existence of maptb isoforms containing this large exon by RT-PCR (Fig. 3C,D) , and then sequenced it. To investigate the evolutionary origin of this large exon, we performed a tBLASTn search in the NCBI database. We failed to find any alignments with significant similarity in well-characterized mammals, chicken, or frog. The only significant match discovered was to a sequence in salmon, with a putative amino acid residue identity of 37% giving an E-value of 9e-27.
To investigate further the pattern of splicing of maptb transcripts, we designed sets of primers for RT-PCR either inside or flanking the four known exons that can be alternatively spliced as indicated by RT-PCR performed above (exons 3, 5, 9, and 12). We showed that all of these exons can co-exist in transcripts (Fig. 3D) . This implies the existence of a considerably complex profile of isoform formation for maptb.
Expression of zebrafish mapta
Using WISH, we could first detect mapta mRNA at 18 hpf in the telencephalon, ventral diencephalon, caudal floorplate of the spinal cord and the hypochord (Fig. 4A,C) . At 24 hpf, expression increases such that it is discernable in both the ventral and dorsal areas of the telencephalon and in the ventral diencephalon, ventral midbrain and hindbrain rhombomeres (Fig. 4B,D) . mapta is expressed in a diffuse manner throughout the spinal cord (Fig. 4B) . At 48 hpf, expression can be detected in ganglion cells of the retina in addition to the regions described above (Fig. 4F) . Meanwhile, expression of mapta in the rhombomeres increases and becomes more widespread to form axial to lateral stripes at this stage. The expression in rhombomere 2 is relatively higher than in other rhombomeres (Fig. 4G) . The expression of mapta in telencephalon, diencephalon, and midbrain is also apparently increased at 48 hpf relative to that seen at 24 hpf and begins to be observable in the cerebellum and tectum. However, expression in the spinal cord apparently decreases (Fig. 4H) .
Expression of zebrafish maptb
The expression pattern of zebrafish maptb partially overlaps that of mapta. However, the transcripts of maptb are detectable by WISH at an earlier stage as compared to mapta. The expression is first evident in the area of the shield at 12 hpf (Fig. 5A) . By 18 hpf, relatively weak expression of maptb mRNA is detected in the ventral diencephalon, midbrain, rhombomeres, and in scattered neurons of the dorsal spinal cord (Fig. 5B) . In contrast, relatively much higher expression of maptb mRNA is observed in the developing trigeminal ganglion, which is located lateral and somewhat caudal to the midbrain-hindbrain boundary (Fig. 5B,C) . At 24 hpf, the expression of maptb mRNA increases and can be observed in ventral telencephalon in addition to the above regions (Fig. 5E ). To better understand the expression domain of maptb, we doublelabeled 27 hpf embryos using the monoclonal antibody zn12 and WISH for maptb. This confirmed expression of maptb in the trigeminal ganglion (Fig. 5H,I ,N) and showed that maptb is expressed in Rohon-Beard neurons (Fig. 5D,F) . Notably, however, mapta expression is not observed in these two regions. At 48 hpf, expression of maptb in brain continues in similar regions as observed at 24 hpf, however, the level of expression appears to be increased (Fig. 5O) . Compared to younger embryos, expression in the telencephalon and diencephalon has expanded in these domains. However, the telencephalon-diencephalon boundary remains visible through its lack of expression (Fig. 5O) . Expression in the hindbrain also becomes more extensive to form an axial to lateral band in each rhombomere (Fig. 5M ) that, nevertheless, is restricted to the ventral half of the hindbrain. In addition, expression of maptb is evident in the cerebellum (Fig. 5M) . In the spinal cord, maptb-expressing neurons show highest expression in more caudal regions (Fig. 5O) .
Our study of maptb mRNA isoforms showed the existence of a particularly long maptb transcript containing an additional 1212 bp exon. Using a riboprobe specific for this exon we could investigate the expression pattern of this "big" isoform by WISH. This showed expression of the big isoform in the trigeminal ganglia and dorsal spinal cord neurons. No expression was detected in the telencephalon, diencephalon, and hindbrain in embryos at 18 hpf and 24 hpf (Fig. 6) . However, relatively much weaker expression in the rostral ventral diencephalon and hindbrain can be detected at 48 hpf by extended staining.
DISCUSSION
The MAPT gene has attracted extensive interest due to its critical role in the development of various neurodegenerative diseases. To achieve a better understanding of MAPT function and dysfunction, multiple animal models have been employed [20] . The zebrafish and its embryos have been demonstrated to be a highly tractable vertebrate model for genetic studies due to a beneficial combination of characteristics including easy embryo accessibility, large embryo size, rapid embryonic development, short generation time, and a well-characterized genome [21] . Indeed, transgenic zebrafish expressing human MAPT have previ-ously been used to investigate MAPT pathology [22, 23] . However, the zebrafish endogenous MAPT gene has not been characterized. Here we identified two MAPT paralogues (mapta and maptb) in zebrafish via a combination of phylogenetic and conserved synteny analysis. These are apparently derived from a duplication of an ancestral teleost MAPT orthologue. Alignments between human MAPT and the zebrafish genes show high conservation in the tubulin-binding domain and the C-terminal tail of the gene. This is the region providing major affinity for MAPT proteins to bind microtubules. The N-terminus of MAPT protein is a "projection domain", which interacts with the axonal membrane [24] . After that is a "hinge region" functioning as a spacer to determine the distance between microtubules in microtubule bundles [25] . In these two regions the amino acid residue sequences of human MAPT and the putative zebrafish proteins do not show conservation. Furthermore, even the two zebrafish MAPT paralogues show low similarity in the N-terminal half, indicating lower selective pressure for sequence conservation of this region or, alternatively, divergent selective pressures on the two paralogues.
The splicing of transcripts from human MAPT shows complex regulation. Of the known 16 exons of human tau, eight (2, 3, 4A, 6, 8, 10, 13, 14) show alternative splicing [3] . Six tau isoforms (derived from alternative splicing of exons 2, 3, and 10) are the major isoforms observed in human brain [26] . The duplicated MAPT paralogues in zebrafish show similar complexity of alternative splicing. For maptb, at least four exons can be spliced alternatively. Our RT-PCR results show that all of the four exons can coexist in transcripts, indicating the existence of a considerable number of splicing isoforms. Interestingly, the maptb gene encodes a particularly large exon (exon 3) that can be alternatively spliced into the N-terminal half of the open reading frame. Inclusion of this exon almost doubles the length of the maptb open reading frame. This is reminiscent of the "big tau" isoform (isoform 6) in humans which also contains a relatively large exon (exon 4A) in its N-terminal region and is specifically expressed in retina and peripheral nervous system [3] . However, blast analysis showed no significant sequence homology between exon 4A of human "big tau" and zebrafish maptb exon 3. In fact, a tBLASTn search in the NCBI nonredundant database failed to find any significant homologies between maptb exon 3 and sequences in mammals, amphibians, and birds.
Alternative splicing of exon 2 and exon 3 of human MAPT produces three protein isoforms with inserts of 0, 29, or 58 amino acid residues in their N-terminal halves [26] . Similarly, zebrafish maptb possesses an exon encoding a putative 58 amino acid residues (exon 5) and this can be alternatively spliced. However, this exon shares no significant sequence similarity with exon 2 or exon 3 of human MAPT and it is located after the large exon. Therefore it remains obscure whether exon 5 of maptb serves a similar function to exon 2 and 3 of human MAPT.
The precise regulation of the ratio of expression of 3R relative to 4R MAPT isoforms has been proposed to be critical for maintaining normal brain function [27] . The disruption of this balance has been found to be correlated with tauopathies [27] . Furthermore, most FTD-associated MAPT mutations alter the level of 3R and 4R MAPT isoforms [28] . Therefore, the tubulinbinding domain plays a significant role in the regulation of MAPT function. Our initial RT-PCR results indicated that maptb might only encode three tubulin-binding repeats. Later, we identified an additional exon encoding a tubulin-binding repeat by a BLAST search of the zebrafish genome sequence. We confirmed the inclusion of this exon in spliced matpb transcripts by RT-PCR. In mouse, 3R Mapt is predominately expressed during embryo development. The 4R isoforms begin to increase by postpartum day 6 (P6) and become the predominant isoforms by P24 [29] . However in zebrafish, the level of 4R transcripts produced from maptb is still relatively very low by 48 hpf (when hatching can begin). On the other hand, we failed to detect any 3R isoforms from the mapta gene by RT-PCR using primers flanking the tubulin-binding domain. Although this does not exclude the possibility of the existence of trace levels of 3R transcript isoforms from mapta, the major mapta transcript products appear to contain four to six tubulin-binding motifs in 24 hpf and 48 hpf embryos. In vitro studies showed that the presence of the fourth tubulin-binding motif in human MAPT almost triples the affinity between MAPT protein and microtubules [30, 31] . Therefore, the inclusion of two additional tubulin-binding motifs may increase the efficiency of Mapta protein in stabilization of microtubules.
WISH showed that mRNA from maptb can be detected earlier than that from mapta. This is not surprising, given that MAPT 3R isoforms are predominant in both human and mouse fetal stages. The expression of maptb also appears relatively stronger than mapta in 18 hpf and 24 hpf embryos (judging by the speed of color development during staining although this can be highly variable and dependent on multiple factors such as embryo batch, fixation time, probe qual-ity, etc.). However, at the 48 hpf stage, the expression level of maptb and mapta appeared to be more similar. Moreover, mapta expression became more spatially extensive compared to maptb covering almost the entire brain region at this stage.
By WISH, we showed that maptb mRNA that includes the large exon 3 is expressed mainly in the trigeminal ganglion and dorsal spinal cord neurons at 24 hpf and 48 hpf. Apart from the observation of very weak expression in anterior ventral diencephalon and hindbrain in 48 hpf embryos after extended straining, the mRNA of this putative zebrafish "big tau" was undetectable in the brain. This coincides with the expression pattern of rat "big tau", which is specifically expressed in the peripheral nervous system [32, 33] . Therefore, although the large exon 3 of zebrafish maptb "big tau" shares no detectable similarity with that of mammalian "big tau" at the amino acid sequence level, their expression patterns appear related, indicating possible conservation of function.
In mice, MAPT expression begins at the E10.0 stage. Expression is detected in brain, retina, spinal cord, and testis, which is consistent with what we observe for mapta and maptb in zebrafish. The similar expression pattern of MAPT in the two species indicates conserved function during evolution. Therefore, zebrafish can be a practical model for study of MAPT and its roles in human neurodegenerative diseases.
The expression patterns of mapta and maptb appear similar in the central nervous system. However, the following differences between the two paralogues were noted: First, maptb is expressed in Rohon-Beard neurons while mapta is expressed in the floorplate and caudal hypochord. In addition, mapta expresses in a diffuse manner in the developing spinal cord, while maptb expression is restricted to Rohon-Beard neurons. At 48 hpf, the expression of mapta in the spinal cord decreased dramatically compared to younger embryos. The expression of maptb in spinal cord neurons also appeared to show a certain level of decrease and became restricted to more caudal regions compared to that in 24 hpf embryos. Second, mapta but not maptb mRNA is detectable in ganglion neurons of the retina. Third, at 48 hpf, the expression of mapta in brain increases and covers a broader region relative to maptb, including the tectum and the dorsal half of the hindbrain. The different expression patterns of mapta and maptb in some regions indicate probable subfunctionalization of the role of an ancestral MAPT orthologue after their formation by duplication. This subfunctionalization may have been enhanced by the changes in the number of tubulin-binding repeats that each gene encodes. Therefore, future study of the functional difference between mapta and maptb may tell us more about how the number of tubulin-binding motifs modifies vertebrate MAPT function.
